Europe - Frankfurt Stock Exchange - FRA:ZOE - US98978V1035 - Common Stock
ZOE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. ZOE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ZOE has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.49% | ||
| ROE | 49.11% | ||
| ROIC | 21.45% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.25% | ||
| PM (TTM) | 28.21% | ||
| GM | 71.71% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.16 | ||
| Altman-Z | 6.42 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.64 | ||
| Quick Ratio | 2.28 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.76 | ||
| Fwd PE | 18.33 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.65 | ||
| EV/EBITDA | 14.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
ChartMill assigns a fundamental rating of 6 / 10 to ZOE.DE.
ChartMill assigns a valuation rating of 4 / 10 to ZOETIS INC (ZOE.DE). This can be considered as Fairly Valued.
ZOETIS INC (ZOE.DE) has a profitability rating of 8 / 10.
The financial health rating of ZOETIS INC (ZOE.DE) is 7 / 10.
The dividend rating of ZOETIS INC (ZOE.DE) is 4 / 10 and the dividend payout ratio is 32.55%.